Source comparison
CJC-1295 Anti-Aging Protocol Dosage Timing: Modified vs Unmodified Comparison
Modified CJC-1295 (with DAC) 1–2mg per dose 1–2× weekly 30–60 minutes before sleep 6–8 days No. DAC sustains GH elevation independently Best for protocols prioritising convenience and sustained GH elevation; produces moderate, continuous increase rather than s
This comparison does not assign a generated winner or score.
- Modified CJC-1295 (with DAC)
- 1–2mg per dose
- 1–2× weekly
- 30–60 minutes before sleep
- 6–8 days
- No. DAC sustains GH elevation independently
- Best for protocols prioritising convenience and sustained GH elevation; produces moderate, continuous increase rather than sharp pulses
- Unmodified CJC-1295 (Mod GRF 1-29)
- 100–200mcg per dose
- 1–3× daily
- Pre-sleep (required), post-workout (optional), fasted morning (optional)
- ~30 minutes
- Yes. Cannot maintain therapeutic levels without GHRP pairing
- Best for protocols requiring pulsatile GH dynamics that mimic natural secretion; more frequent administration but closer to physiological GH release pattern
- Unmodified CJC-1295 + Ipamorelin
- 100–200mcg CJC + 200–300mcg ipamorelin per dose
- Same as unmodified CJC; inject both peptides simultaneously
- CJC ~30 min / Ipamorelin ~2 hours
- N/A. Combination protocol
- Ipamorelin's selectivity for GH release with minimal ghrelin/cortisol impact makes it the preferred GHRP for anti-aging research; combined half-lives support 2–3× daily dosing
- Unmodified CJC-1295 + GHRP-2
- 100–200mcg CJC + 100–200mcg GHRP-2 per dose
- Same timing; GHRP-2 produces stronger GH pulse than ipamorelin
- CJC ~30 min / GHRP-2 ~30 min
- GHRP-2 amplifies GH release more aggressively than ipamorelin but also increases cortisol and prolactin slightly; suitable for research contexts where maximal GH output is prioritised